Protective effects of taurine against oxidative stress in the heart of MsrA knockout mice

Journal of Cellular Biochemistry

Volumn 113, Issue 11, 2012, Pages 3559-3566

  Chen, G ^a,b,d   Nan, C ^b   Tian, Jie ^a   Jean Charles, P ^b   Li, Y ^b,e   Weissbach, H ^c   Huang, X P ^b,c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

^d YANTAI YUHUANGDING HOSPITAL   (China)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ANTI OXIDANT; DIET SUPPLEMENT; HEART; MITOCHONDRIA; TAURINE

Indexed keywords

ANTIOXIDANT; CALCIUM; METHIONINE SULFOXIDE REDUCTASE A; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ASSAY; CONTROLLED STUDY; DIET SUPPLEMENTATION; ECHOCARDIOGRAPHY; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; IN VIVO STUDY; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; CALCIUM; DIETARY SUPPLEMENTS; ECHOCARDIOGRAPHY; HEART; HEART FUNCTION TESTS; HYDROGEN PEROXIDE; METHIONINE SULFOXIDE REDUCTASES; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; OXIDATIVE STRESS; TAURINE;

ANIMALIA; MUS;

EID: 84866512611     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24233     Document Type: Article

References (42)

1. Azuma J, Sawamura A, Awata N, Ohta H, Hamaguchi T, Harada H, Takihara K, Hasegawa H, Yamagami T, Ishiyama T, et al. 1985. Therapeutic effect of taurine in congestive heart failure: A double-blind crossover trial. Clin Cardiol 8: 276-282.
2. Azuma J, Sawamura A, Awata N,. 1992. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J 56: 95-99.
3. Bouckenooghe T, Remacle C, Reusens B,. 2006. Is taurine a functional nutrient ? Curr Opin Clin Nutr Metab Care 9: 728-733.
4. Chang L, Xu J, Yu F, Zhao J, Tang X, Tang C,. 2004. Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats. Amino Acids 27: 37-48.
5. Du J, Zhang C, Liu J, Sidky C, Huang XP,. 2006. A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice. Arch Biochem Biophys 456: 143-150.
6. Du J, Liu J, Feng HZ, Hossain MM, Gobara N, Zhang C, Li Y, Jean-Charles PY, Jin JP, Huang XP,. 2008. Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI. Am J Physiol Heart Circ Physiol 294: H2604-H2613.
7. Feigenbaum H, Ryan T AW,. 2005. Evaluation of systolic and diastolic function of the left ventricle. Feigenbaum's Echocardiography. PA: Lippincott Williams & Wilkins.
8. Ghesquière B, Jonckheere V, Colaert N, Van Durme J, Timmerman E, Goethals M, Schymkowitz J, Rousseau F, Vandekerckhove J, Gevaert K,. 2011. Redox proteomics of protein-bound methionine oxidation. Mol Cell Proteomics 10: 1074-1086.
9. Hanna J, Chahine R, Aftimos G, Nader M, Mounayar A, Esseily F, Chamat S,. 2004. Protective effect of taurine against free radicals damage in the rat myocardium. Exp Toxicol Pathol 56: 189-194.
10. Hansen SH, Andersen ML, Birkedal H, Cornett C, Wibrand F,. 2006. The important role of taurine in oxidative metabolism. Adv Exp Med Biol 583: 129-135.
11. Hansen SH, Andersen ML, Cornett C, Gradinaru R, Grunnet N,. 2010. A role for taurine in mitochondrial function. J Biomed Sci 17 (Suppl. 1): S23.
12. Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J,. 2008. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44: 927-937.
13. Jeejeebhoy F, Keith M, Freeman M, Barr A, McCall M, Kurian R, Mazer D, Errett L,. 2002. Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. Am Heart J 143: 1092-1100.
14. Jia Y, Akerman S, Huang X,. 2004. Myofibril MgATPase activities and energy metabolism in cardiomyopathic mice with diastolic dysfunction. J Biomed Sci 11: 450-456.
15. Keith ME, Ball A, Jeejeebhoy KN, Kurian R, Butany J, Dawood F, Wen WH, Madapallimattam A, Sole MJ,. 2001. Conditioned nutritional deficiencies in the cardiomyopathic hamster heart. Can J Cardiol 17: 449-458.
16. Levine RL, Mosoni L, Berlett BS, Stadtman ER,. 1996. Methionine residues as endogenous antioxidants in proteins. Proc Nat Acad Sci USA 93: 15036-15040.
17. Levine RL, Moskovitz J, Stadtman ER,. 2000. Oxidation of methionine in proteins: Roles in antioxidant defense and cellular regulation. IUBMB Life 50: 301-307.
18. 2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy. J Mol Cell Cardiol 49: 402-411.
19. Marin-Garcia J, Goldenthal MJ,. 2002. Understanding the impact of mitochondrial defects in cardiovascular disease: A review. J Cardiac Fail 8: 347-361.
20. Martinez-Gonzalez MA, Bes-Rastrollo M, Serra-Majem L, Lairon D, Estruch R, Trichopoulou A,. 2009. Mediterranean food pattern and the primary prevention of chronic disease: Recent developments. Nutr Rev 67 (Suppl. 1): S111-S116.
21. Militante JD, Lombardini JB,. 2002. Treatment of hypertension with oral taurine: Experimental and clinical studies. Amino Acids 23: 381-393.
22. Moskovitz J, Flescher E, Berlett BS, Azare J, Poston JM, Stadtman ER,. 1998. Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc Nat Acad Sci USA 95: 14071-14075.
23. Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, Stadtman ER,. 2001. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Nat Acad Sci USA 98: 12920-12925.
24. Nan C, Li Y, Jean-Charles PY, Chen G, Kreymerman A, Prentice H, Weissbach H, Huang X,. 2010. Deficiency of methionine sulfoxide reductase A causes cellular dysfunction and mitochondrial damage in cardiac myocytes under physical and oxidative stresses. Biochem Biophys Res Commun 402: 608-613.
25. Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER,. 1987. Age-related changes in oxidized proteins. J Biol Chem 262: 5488-5491.
26. Oudit GY, Trivieri MG, Khaper N, Husain T, Wilson GJ, Liu P, Sole MJ, Backx PH,. 2004. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation 109: 1877-1885.
27. Picot CR, Perichon M, Lundberg KC, Friguet B, Szweda LI, Petropoulos I,. 2006. Alterations in mitochondrial and cytosolic methionine sulfoxide reductase activity during cardiac ischemia and reperfusion. Exp Gerontol 41: 663-667.
28. Prentice HM, Moench IA, Rickaway ZT, Dougherty CJ, Webster KA, Weissbach H,. 2008. MsrA protects cardiac myocytes against hypoxia/reoxygenation induced cell death. Biochem Biophys Res Commun 366: 775-778.
29. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA,. 2002. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15: 167-184.
30. Ruan H, Tang XD, Chen ML, Joiner ML, Sun G, Brot N, Weissbach H, Heinemann SH, Iverson L, Wu CF, Hoshi T,. 2002. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Nat Acad Sci USA 99: 2748-2753.
31. Sadek HA, Nulton-Persson AC, Szweda PA, Szweda LI,. 2003. Cardiac ischemia/reperfusion, aging, and redox-dependent alterations in mitochondrial function. Arch Biochem Biophys 420: 201-208.
32. Sahn DJ, DeMaria A, Kisslo J, Weyman A,. 1978. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 58: 1072-1083.
33. Salmon AB, Perez VI, Bokov A, Jernigan A, Kim G, Zhao H, Levine RL, Richardson A,. 2009. Lack of methionine sulfoxide reductase A in mice increases sensitivity to oxidative stress but does not diminish life span. FASEB J 23: 3601-3608.
34. Sofi F,. 2009. The Mediterranean diet revisited: Evidence of its effectiveness grows. Curr Opin Cardiol 24: 442-446.
35. Warskulat U, Heller-Stilb B, Oermann E, Zilles K, Haas H, Lang F, Haussinger D,. 2007. Phenotype of the taurine transporter knockout mouse. Methods Enzymol 428: 439-458.
36. Weissbach H, Resnick L, Brot N,. 2005. Methionine sulfoxide reductases: History and cellular role in protecting against oxidative damage. Biochim Biophys Acta 1703: 203-212.
37. Wojcik OP, Koenig KL, Zeleniuch-Jacquotte A, Costa M, Chen Y,. 2010. The potential protective effects of taurine on coronary heart disease. Atherosclerosis 208: 19-25.
38. Wojcik OP, Koenig KL, Zeleniuch-Jacquotte A, Pearte C, Costa M, Chen Y,. 2012. Serum taurine and risk of coronary heart disease: A prospective, nested case-control study. Eur J Nutr
39. Yermolaieva O, Xu R, Schinstock C, Brot N, Weissbach H, Heinemann SH, Hoshi T,. 2004. Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation. Proc Nat Acad Sci USA 101: 1159-1164.
40. Zeybek A, Ercan F, Cetinel S, Cikler E, Saglam B, Sener G,. 2006. Taurine ameliorates water avoidance stress-induced degenerations of gastrointestinal tract and liver. Dig Dis Sci 51: 1853-1861.
41. Zeybek A, Saglam B, Cikler E, Cetinel S, Ercan F, Sener G,. 2007. Taurine ameliorates stress-induced degeneration of the urinary bladder. Acta Histochem 109: 208-214.
42. Zhao H, Sun J, Deschamps AM, Kim G, Liu C, Murphy E, Levine RL,. 2011. Myristoylated methionine sulfoxide reductase A protects the heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 301: H1513-H1518.